NCT02381561 - Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

November 8, 2018

Study Completion Date

March 14, 2026

Conditions

Advanced Bile Duct CarcinomaStage II Esophageal Cancer AJCC v7Stage II Pancreatic Cancer AJCC v6 and v7Stage IIA Esophageal Cancer AJCC v7Stage IIA Pancreatic Cancer AJCC v6 and v7Stage IIB Esophageal Cancer AJCC v7Stage IIB Pancreatic Cancer AJCC v6 and v7Stage III Colon Cancer AJCC v7Stage III Esophageal Cancer AJCC v7Stage III Gastric Cancer AJCC v7Stage III Liver CancerStage III Pancreatic Cancer AJCC v6 and v7Stage III Rectal Cancer AJCC v7Stage III Small Intestinal Cancer AJCC v7Stage IIIA Colon Cancer AJCC v7Stage IIIA Esophageal Cancer AJCC v7Stage IIIA Gastric Cancer AJCC v7Stage IIIA Rectal Cancer AJCC v7Stage IIIA Small Intestinal Cancer AJCC v7Stage IIIB Colon Cancer AJCC v7Stage IIIB Esophageal Cancer AJCC v7Stage IIIB Gastric Cancer AJCC v7Stage IIIB Rectal Cancer AJCC v7Stage IIIB Small Intestinal Cancer AJCC v7Stage IIIC Colon Cancer AJCC v7Stage IIIC Esophageal Cancer AJCC v7Stage IIIC Gastric Cancer AJCC v7Stage IIIC Rectal Cancer AJCC v7Stage IV Colon Cancer AJCC v7Stage IV Esophageal Cancer AJCC v7Stage IV Gastric Cancer AJCC v7Stage IV Liver CancerStage IV Pancreatic Cancer AJCC v6 and v7Stage IV Rectal Cancer AJCC v7Stage IV Small Intestinal Cancer AJCC v7Stage IVA Colon Cancer AJCC v7Stage IVA Liver CancerStage IVA Rectal Cancer AJCC v7Stage IVB Colon Cancer AJCC v7Stage IVB Liver CancerStage IVB Rectal Cancer AJCC v7

Interventions

RADIATION

Intensity-Modulated Radiation Therapy

Undergo IMRT

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Pharmacological Study

Correlative studies

DRUG

Ropidoxuridine

Given PO

Trial Locations (1)

02903

Rhode Island Hospital, Providence

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH